Abstract:What's new? Cancer diagnoses declined in Belgium in 2020, following the onset of the COVID‐19 pandemic. An ageing population and migration, however, suggest that the actual pandemic impact on cancer trends in Belgium is underestimated. This study assessed cancer incidence, stage distribution and survival during the COVID‐19 pandemic using cancer registry data in Belgium. By the end of 2020, the number of expected cancer diagnoses was found to have declined by more than 5000. Incidence of early‐stage cancers was reduced, and shifts in stage distribution were observed. Whether stage shifts are associated with delayed diagnosis during the pandemic warrants further investigation. The COVID‐19 pandemic was associated with a profound decline in cancer diagnoses in 2020 in Belgium. Disruption in diagnostic and screening services and patient reluctance to visit health facilities led to fewer new cases and concerns that cancers may be diagnosed at more advanced stages and hence have poorer prognosis. Using data from mandatory cancer registration covering all of Belgium, we predicted cancer incidence, stage distribution and 1‐year relative survival for 2020 using a Poisson count model over the preceding years, extrapolated to 2020 for 11 common cancer types. We compared these expected values to the observed values in 2020 to specifically quantify the impact of the COVID‐19 pandemic, accounting for background trends. A significantly lower incidence was observed for cervical, prostate, head and neck, colorectal, bladder and breast cancer, with limited or no recovery of diagnoses in the second half of 2020 for these cancer types. Changes in stage distribution were observed for cervical, prostate, bladder and ovarian and fallopian tube tumours. Generally, changes in stage distribution mainly represented decline in early‐stage than in late‐stage tumours. One‐year relative survival was lower than predicted for lung cancer and colorectal cancer. Stage shifts are hypothesised to result from alterations in access to diagnosis, potentially due to prioritisation of symptomatic patients, and patient reluctance to contact a physician. Since there were over 5000 fewer cancer diagnoses than expected by the end of 2020, it is critical to monitor incidence, stage distribution and survival for these cancers in the coming years.

The epidemiology of the most frequent cancers in Poland in 2015–2021 and the impact of the COVID-19 pandemic on cancer incidence

The impact of the COVID-19 pandemic on incidence gap in screen-detectable cancers: a cohort study in Greater Poland, Poland

The Concept of Health Debt Incurred during the COVID-19 Pandemic on the Example of Basal Cell Skin Cancer Diagnosis in Lower Silesia

Cancer incidence and mortality in Poland in 2019

Epidemiology of penile cancer in Poland compared to other European countries

Impacts of the COVID-19 pandemic on the breast cancer control pathway in Ireland

Impact of COVID-19 on the functioning of medical facilities in Poland

The landscape of the COVID-19 pandemic in Poland emerging from epidemiological and genomic data

Estimation of the Impact of COVID-19 Pandemic Lockdowns on Breast Cancer Deaths and Costs in Poland using Markovian Monte Carlo Simulation

Cervical Cancer Prevention in the Era of the COVID-19 Pandemic

Infectious diseases in Poland in 2021

Impact of the COVID-19 Pandemic and Lockdown on Cancer Diagnoses Using Swiss Cantonal Cancer Registry Data

The Impact of the COVID-19 Pandemic on Cancer Mortality in Pennsylvania: A Retrospective Study with Geospatial Analysis

How COVID-19 has changed the utilization of different health care services in Poland

Impact of the SARS-CoV-2 (COVID-19) Pandemic on Characteristics and Management of Uveal Melanoma in the National Referral Center in Poland

Annual Report to the Nation on the Status of Cancer, part 2: Early assessment of the COVID‐19 pandemic’s impact on cancer diagnosis

The COVID-19 pandemic and Poland’s macroeconomic situation

Cancer incidence, stage shift and survival during the 2020 COVID‐19 pandemic: A population‐based study in Belgium

Impact of COVID-19 on 2021 cancer incidence rates and potential rebound from 2020 decline

Impact of COVID-19 Pandemic on Health and Life Emergencies Resulting from Illness Cases and Injuries—A Preliminary Study

The Assessment of Knowledge About Cervical Cancer, HPV Vaccinations, and Screening Programs Among Women as an Element of Cervical Cancer Prevention in Poland